PRECIGEN, INC. Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount
PRECIGEN, INC. (PGEN) had Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount of $0 as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Notes
us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount · last filed 2022-11-09
- 2022-09-30: Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount $0.00.
- 2022-06-30: Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount $0.00.
- 2022-03-31: Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount $0.00.
- 2021-12-31: Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount $0.00.
| Period end | Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount | Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount as first filed |
|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-09 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 | |
| 2020-09-30 | $337.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $859.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.11M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.46M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $20.45M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $20.24M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $19.91M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.34M 10-K · filed 2020-03-02 | $21.22M 10-K · filed 2019-03-01 |
| 2018-09-30 | $179.43M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $177.88M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $191.73M 10-Q/A · filed 2018-08-13 | |
| 2017-12-31 | $185.26M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $187.56M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $185.56M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $165.94M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $159.12M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $145.79M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $137.92M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $15.60M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $3.60M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $1.91M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $557.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $192.23M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $0.00 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |